BioGaia AB Series B | Ownership

Companies that own BioGaia AB Series B

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Swedbank Robur Fonder AB
1,626,000
9.8%
392,619
0.12%
12/31/2017
Old Mutual International Isle of Man Ltd. (Invt Mgmt)
1,370,165
8.26%
270,165
96.26%
01/27/2017
Fjärde AP-fonden
1,243,000
7.49%
16,791
0.34%
12/31/2017
Banque Pictet & Cie SA
478,000
2.88%
478,000
0.41%
12/31/2017
Norges Bank Investment Management
456,000
2.75%
456,000
0%
12/31/2017
Tredje AP-fonden
316,000
1.9%
174,000
0.13%
12/31/2017
AMF Fonder AB
237,000
1.43%
-7,000
0.06%
12/31/2017
E. Öhman J :or Fonder AB
236,824
1.43%
68,174
0.27%
12/31/2017
Allianz Global Investors GmbH
219,375
1.32%
0
0.01%
05/31/2018
Nordea Investment Management AB
216,315
1.3%
-113,167
0.04%
05/31/2018

About BioGaia AB

View Profile
Address
Kungsbroplan 3
Stockholm AB 112 27
Sweden
Employees -
Website http://www.biogaia.com
Updated 07/08/2019
BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment is comprised of sales of drops, oral rehydration solutions (ORS), digestive health tablets and also cultures as an ingredient in a licensee's products, as well as royalties pertaining to pediatric products.